This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Gastroenterology  • Liver/ Biliary Tract/ Pancreatic Diseases  • Infectious Diseases  • HIV/AIDS  • Viral Infections  • Pediatrics, Other  • Alert me on articles by topic

Arch Pediatr Adolesc Med. 2005;159:598-599.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We read with interest the recent report by Schuval et al¹ regarding the Pediatric AIDS Clinical Trials Group Protocol (PACTG) 1028S study on coinfection with hepatitis C virus (HCV) in children infected with human immunodeficiency virus 1 (HIV-1). The goal of the study was commendable, though the small number of coinfected children who were identified highlights the difficulties inherent to the study of this population. Given these limitations, enrollment might have been increased by including children younger than 1 year. Concerns over false-positive results due to maternal antibodies are unwarranted when HCV RNA testing is performed. In retrospect, it is unfortunate that only a subset of the 3000 subjects in the PACTG 219C study were enrolled in this substudy.

All 8 children identified were reported as having normal liver biochemistry results. However, the apparent absence of overt liver disease observed in this coinfected population may have been due to the . . . [Full Text of this Article]

AUTHOR INFORMATION

Steven R. Martin, MD; Normand Lapointe, MD; Hugo Soudeyns, PhD

RELATED ARTICLE

Coinfection With Hepatitis C Virus and Human Immunodeficiency Virus 1 in Children: Pathogenesis and Screening—Reply
Susan J. Schuval
Arch Pediatr Adolesc Med. 2005;159(6):599.
EXTRACT | FULL TEXT